Skip to main content
Log in

Antigenic similarity between the protein neurotoxin α-bungarotoxin and neuromuscular blocking drugs

  • Histamine and Kinins
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The snake neurotoxins α-bungarotoxin (α-BGT) and β-bungarotoxin (β-BGT) which act at the neuromuscular junction, were found to bind to IgE antibodies directed against neuromuscular blocking (NMB) drugs in the sera of two patients who had experienced lifethreatening anaphylactic reactions to succinylcholine. α-BGT inhibited IgE-binding to a choline-Sepharose solid support in one patient better than the NMB drug alcuronium, choline, triethylcholine and β-BGT. IC50s for α-BGT and succinylcholine were 16 and 10 nmol respectively for one patient and 34 and 6.0 nmol for the other.

Recognition of the NMB drugs and α-BGT by the same antibody is the first demonstration of an antigenic similarity between these drugs and the protein toxin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E.A. Barnard, J. Wieckowski andT.N. Chiu,Cholinergic receptor molecules and cholinesterase molecules at mouse skeletal muscle junctions, Nature234, 207–209 (1971).

    PubMed  Google Scholar 

  2. D.K. Berg, R.B. Kelly, P.B. Sargent, P. Williamson andZ.W. Hall,Binding of α-bungarotoxin to acetylcholine receptors in mammalian muscle, Proc. Nat. Acad. Sci.69, 147–151 (1972).

    PubMed  Google Scholar 

  3. D.M. Fambrough andH.C. Hartzell,Acetylcholine receptors: number and distribution at neuromuscular junctions in rat diaphragm, Science176, 189–191 (1972).

    PubMed  Google Scholar 

  4. J. Patrick, S.F. Heinemann, J. Lindstrom, D.R. Schubert andJ.H. Steinbach,Appearance of acetylcholine receptors during differentiation of a myogenic cell line, Proc. Nat. Acad. Sci.69, 2762–2766 (1972).

    PubMed  Google Scholar 

  5. A.J. Sytkowski, Z. Vogel andM.W. Nirenberg,Development of acetylcholine receptor clusters on cultured muscle cells, Proc. Nat. Acad. Sci.70, 270–274 (1973).

    PubMed  Google Scholar 

  6. J.O. Dolly andE.A. Barnard,Purification and characterization of an acetylcholine receptor from mammalian skeletal muscle, Biochemistry16, 5053–5060 (1977).

    Article  PubMed  Google Scholar 

  7. J.P. Changeux, M. Kasai andC.Y. Lee,Use of a snake venom toxin to characterize the cholinergic receptor protein, Proc. Nat. Acad. Sci.67, 1241–1247 (1970).

    PubMed  Google Scholar 

  8. R. Miledi, P. Molinoff andL.T. Potter,Isolation of the cholinergic receptor protein of Torpedo electric tissue, Nature229, 554–557 (1971).

    PubMed  Google Scholar 

  9. D. Mebs, K. Narita, S. Iwanaga, Y. Samejima andC.Y. Lee,Purification, properties and amino acid sequence of α-bungarotoxin from the venom of Bungarus multicinctus, Hoppe-Seyler's Z. Physiol. Chem.353, 243–262 (1972).

    PubMed  Google Scholar 

  10. C.Y. Lee,Chemistry and pharmacology of polypeptide toxins in snake venoms, Ann. Rev. Pharmacol.12, 265–286 (1972).

    Article  PubMed  Google Scholar 

  11. P. Taylor,Neuromuscular blocking agents. In:The Pharmacological Basis of Therapeutics, 6th edition (Ed.A. Goodman Gilman,L.S. Goodman andA. Gilman) pp 220–234. MacMillan, New York 1980.

    Google Scholar 

  12. T. Heidmann andJ.P. Changeux,Structural and functional properties of the acetylcholine receptor protein in its purified and membrane-bound states, Ann. Rev. Biochem.47, 317–357 (1978).

    Article  PubMed  Google Scholar 

  13. B.A. Baldo andM.M. Fisher,Substituted ammonium ions as allergenic determinants in drug allergy, Nature306, 262–264 (1983).

    Article  PubMed  Google Scholar 

  14. B.A. Baldo andM.M. Fisher,Detection of serum IgE antibodies that react with alcuronium and tubocurarine after lifethreatening reactions to muscle relaxant drugs, Anaesth. Intens. Care11, 194–197 (1983).

    Google Scholar 

  15. D.G. Harle, B.A. Baldo andM.M. Fisher,Detection of IgE antibodies to suxamethonium after anaphylactoid reactions during anaesthesia, Lancet i, 930–932 (1984).

    Article  Google Scholar 

  16. D.G. Harle, B.A. Baldo andM.M. Fisher,Assays for, and cross-reactivities of, IgE antibodies to the muscle relaxants gallamine, decamethonium and succinylcholine (suxamethonium). J. Immunol. Methods78, 293–305 (1985).

    Article  PubMed  Google Scholar 

  17. B.A. Baldo andM.M. Fisher,Anaphylaxis to muscle relaxant drugs: cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay, Molec. Immunol.20, 1393–1400 (1983).

    Article  Google Scholar 

  18. D.G. Harle, B.A. Baldo andM.M. Fisher,Cross-reactivity of metocurine, atracurium, vecuronium and fazadinium with IgE antibodies from patients unexposed to these drugs but allergic to other myoneural blocking drugs, Br. J. Anaesth.57, 1073–1076 (1985).

    PubMed  Google Scholar 

  19. B.A. Baldo, D.G. Harle andM.M. Fisher,In vitro diagnosis and studies on the mechanism(s) of anaphylactoid reactions to muscle relaxant drugs, Ann. Fr. Anesth. Réanim.4, 139–145 (1985).

    Google Scholar 

  20. R.R. Neubig, N.D. Boyd andJ.B. Cohen,Conformations of Torpedo acetylcholine receptor associated with ion transport and desensitization, Biochemistry21, 3460–3467 (1982).

    Article  PubMed  Google Scholar 

  21. R.E. Sheridan andH.A. Lester,Fuctional stoichiometry at the nicotinic receptor, J. Gen. Physiol.80, 499–516 (1982).

    Article  PubMed  Google Scholar 

  22. D. Bovet,Synthetic inhibitors of neuromuscular transmission, chemical structures and structure activity relationships. In:Neuromuscular Blocking and Stimulating Agents Vol. 1, International Encyclopedia of Pharmacology and Therapeutics, Section 14, (Ed.J. Cheymol), pp 143–294. Pergamon Press, Oxford 1972.

    Google Scholar 

  23. R.B. Kelly andF.R. Brown III,Biochemical and physiological properties of a purified snake venom neurotoxin which acts presynaptically, J. Neurobiology5, 135–150 (1974).

    Article  Google Scholar 

  24. P. Lesca andC. Paoletti,A protein inhibitor of acid deoxyribonucleases, Proc. Nat. Acad. Sci.64, 913–919 (1969).

    PubMed  Google Scholar 

  25. M. Laskowski andM. Laskowski Jr,Naturally occurring trypsin inhibitors, Advan. Protein Chem.9, 203–242 (1954).

    Google Scholar 

  26. D. Tsernoglou andG. Petsko,The crystal structure of a post-synaptic neurotoxin from sea snake at 2.2 Å resolution, FEBS lett.68, 1–4 (1976).

    PubMed  Google Scholar 

  27. B.W. Low, H.S. Preston, A. Sato, L.S. Rosen, J.E. Searl, A.D. Rudko andJ.S. Richardson,Three dimensional structure of erabutoxin b neurotoxic protein: inhibitor of acetylcholine receptor, Proc. Nat. Acad. Sci.73, 2991–2994 (1976).

    PubMed  Google Scholar 

  28. D. Tsernoglou andG. Petsko,Three dimensional structure of neurotoxin a from venom of the Philippines sea snake, Proc. Nat. Acad. Sci.74, 971–974 (1977).

    PubMed  Google Scholar 

  29. G.K. Wang, S. Molinaro andJ. Schmidt,Ligand responses of α-bungarotoxin binding sites from skeletal muscle and optic lobe of the chick, J. Biol. Chem.253, 8507–8512 (1978).

    PubMed  Google Scholar 

  30. G.A. Grant andV.A. Chiappinelli,ϰ-Bungarotoxin: complete amino acid sequence of a neuronal nicotinic receptor probe, Biochem.24, 1532–1537 (1985).

    Article  Google Scholar 

  31. L. Saiani, H. Kageyama, B.M. Conti-Tronconi andA. Guidotti,Purification and characterization of a bungaro-toxin polypeptide which blocks nicotinic receptor function in primary culture of adrenal chromaffin cells, Molec. Pharmacol.25, 327–334 (1984).

    Google Scholar 

  32. E.A. Kabat,Structural concepts in Immunology and Immunochemistry, 2nd edition. Holt, Rinehart and Winston, New York 1976.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harle, D.G., Baldo, B.A. & Fisher, M.M. Antigenic similarity between the protein neurotoxin α-bungarotoxin and neuromuscular blocking drugs. Agents and Actions 18, 512–517 (1986). https://doi.org/10.1007/BF01964956

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01964956

Keywords

Navigation